Skip to main content

GOLDMAN SACHS GROUP INC

Position in ACRV — Acrivon Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in ACRV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$26,557
+$6,066 QoQ
Shares Held
14,920
+1.2% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 46 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACRV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. ACRV ranks #343 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACRV

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,557 14,920
2026-03-31 $20,491 14,742
2025-12-31 $287,807 119,422
2025-09-30 $35,733 19,742
2025-06-30 $166,665 140,055
2025-03-31 $116,763 57,519
2024-12-31 $1,430,063 237,552
2024-09-30 $1,387,176 198,168
2024-06-30 $141,427 24,384
2023-03-31 $174,081 13,718
2022-12-31 $446,976 38,800